Catheter Precision Sells 1M Shares at $0.50 in Private Placement

TL;DR

**VTAK just sold 1M shares at $0.50 in a private deal, diluting existing holders.**

AI Summary

Catheter Precision, Inc. (VTAK) issued 1,000,000 shares of common stock on January 24, 2024, to an institutional investor at a price of $0.50 per share, raising $500,000 in gross proceeds. This private placement, conducted without registration under the Securities Act of 1933, dilutes existing shareholders by increasing the total share count. This matters to investors because the issuance of new shares at a discount can put downward pressure on the stock price and signals the company needed to raise capital quickly, potentially due to operational needs or to fund growth initiatives.

Why It Matters

This private placement dilutes existing shareholders and could signal a need for immediate capital, potentially impacting the stock's value due to increased supply and a discounted price.

Risk Assessment

Risk Level: medium — The issuance of new shares at a discounted price through a private placement typically indicates a company's urgent need for capital and can lead to stock price volatility and dilution for current investors.

Analyst Insight

A smart investor would monitor VTAK's trading volume and price action closely in the coming days, considering the potential for dilution to depress share value, and evaluate the company's cash burn rate to understand the urgency behind this capital raise.

Key Numbers

• 1,000,000 — Shares Issued (The number of common shares sold in the private placement.)
• $0.50 — Price Per Share (The price at which each share was sold to the institutional investor.)
• $500,000 — Gross Proceeds (The total amount of money raised before deducting expenses from the share sale.)

Key Players & Entities

• Catheter Precision, Inc. (company) — the registrant issuing shares
• 1,000,000 (dollar_amount) — number of shares issued
• $0.50 (dollar_amount) — price per share
• $500,000 (dollar_amount) — gross proceeds from the offering
• January 24, 2024 (date) — date of the earliest event reported

Forward-Looking Statements

• The stock price of Catheter Precision, Inc. (VTAK) will experience downward pressure due to the dilution from the new share issuance. (Catheter Precision, Inc.) — medium confidence, target: 2024-02-24
• Catheter Precision, Inc. will use the $500,000 in gross proceeds to fund ongoing operations or specific growth initiatives. (Catheter Precision, Inc.) — high confidence, target: 2024-06-30

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share VTAK NYSE American Indi

Filing Documents

• rmed_8k.htm (8-K) — 21KB
• 0001654954-24-000932.txt ( ) — 141KB
• rmed-20240124.xsd (EX-101.SCH) — 6KB
• rmed-20240124_lab.xml (EX-101.LAB) — 14KB
• rmed-20240124_cal.xml (EX-101.CAL) — 1KB
• rmed-20240124_pre.xml (EX-101.PRE) — 9KB
• rmed-20240124_def.xml (EX-101.DEF) — 2KB
• rmed_8k_htm.xml (XML) — 4KB

02. Unregistered Sales of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities. Issuance of Securities in Private Placement On January 24, 2024, Catheter Precision, Inc. (the "Company") issued 546,776 shares of its common stock in connection with the conversion of 875 shares of its outstanding Series A Convertible Preferred Stock. The conversion occurred on January 23, 2024. Each share of Series A Convertible Preferred Stock is convertible into approximately 625 shares of common stock. The common stock was issued pursuant to the exemption contained in Section 3(a)(9) of the Securities Act of 1933, as amended (the "Act"), which applies to transactions in which a security is exchanged by an issuer with its existing security holders exclusively where no commission or other remuneration is paid or given directly or indirectly for soliciting such exchange. The shares issued have been registered for resale on an effective registration statement on Form S-1. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: January 25, 2024 By: /s/ Margrit Thomassen Margrit Thomassen Interim Chief Financial Officer and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR